Suspended and Revoked Manufacturing and Wholesale Distribution Authorisations by MHRA

This page provides a comprehensive list of Manufacturing and Wholesale Distribution authorisations that have been suspended or revoked by the Medicines and Healthcare products Regulatory Agency (MHRA). These actions are taken to ensure public safety and maintain the integrity of the UK’s healthcare system.

Mitigate risk with our comprehensive screening solutions for your AML and sanctions compliance.
98 Entities in Suspended and Revoked Manufacturing and Wholesale Distribution Authorisations by MHRA
Entity NameEntity TypeEffective DateStatus

Primius Lab Limited

CompanyNov 24, 2022active

BIRCH AND BEECH LIMITED

CompanyOct 16, 2018active

RAM ENTERPRISE WHOLESALE LIMITED

CompanyMar 1, 2016active

OCTAVIAN PHARMA LIMITED

CompanyOct 1, 2015active

Bristol Laboratories Limited

CompanyNov 13, 2023active

SUPAMED LIMITED

CompanyAug 17, 2018active

Medicine Box Limited

CompanyJan 16, 2024active

Medicine Box Ltd

CompanyJul 21, 2022inactive

ISS PHARMACEUTICALS LIMITED

CompanyMar 22, 2017active

GALAXY PHARMA LIMITED

CompanyJun 30, 2017active

FAQs

Why is compliance with Suspended Medicaid Providers by Nevada Department of Health and Human Services necessary?

It is crucial to comply with the list of Suspended Medicaid Providers published by the Nevada Department of Health and Human Services. This list identifies healthcare providers who are no longer allowed to participate in the medicaid program due to various issues, including fraud, misconduct, or failure to meet regulatory standards.

Which companies should comply with Suspended Medicaid Providers by Nevada Department of Health and Human Services?

Healthcare providers and organizations offering Medicaid services in Nevada must comply with the suspended Medicaid providers list. This includes hospitals, clinics, and individual practitioners. Ensuring compliance is crucial to prevent financial penalties and protect the integrity of Medicaid programs. Non-compliance can lead to loss of funding and damage the reputation of healthcare providers.